1. "Anna Mckenney"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (5)
Groups
  1. Alumni (GSK) (18)
  2. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (18)
  3. Department of Medicine (15)
  4. Hematologic Malignancies, Division of (14)
  5. Adult Leukemia (12)
  6. Center for Hematologic Malignancies (12)

More Groups

People
  1. Anna Mckenney (18)
  2. Ross Levine (12)
  3. Raajit Rampal (7)
  4. Franck Rapaport (4)
  5. Jihae Ahn (4)
  6. Kaitlyn Shank (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2019 (1)
  4. 2018 (3)
  5. 2017 (1)
  6. 2016 (1)

More Years

Publications
  1. Blood (5)
  2. Journal of Clinical Investigation (2)
  3. Academic Medicine (1)
  4. Advances in Radiation Oncology (1)
  5. Cancer Cell (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. American Society for Clinical Investigation (2)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)
  5. Cell Press (1)
  6. Elsevier Inc. (1)

More Publishers

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiomic analysis to predict histopathologically confirmed pseudoprogression in glioblastoma patients
    Journal Article

    McKenney, A. S.; Weg, E.; Bale, T. A.; Wild, A. T.; Um, H.; Fox, M. J.; Lin, A.; Yang, J. T.; Yao, P.; Birger, M. L.; more...
    Advances in Radiation Oncology (2023)

    Fulltext@MSK | Save
  • COVID-19 in patients with cancer: Can baseline radiologic severity and early evolution predict clinical outcomes?
    Journal Article

    Perez-Johnston, R.; Araujo-Filho, J.; McKenney, A. S.; Gangai, N.; Plodkowski, A. J.; Liu, C. C.; Sawan, P.; Taur, Y.; Morjaria, S. M.; Ginsberg, M. S.
    European Radiology (2022)

    Fulltext@MSK | Save
  • MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors
    Journal Article

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; Tixier, F.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • MRI texture features and outcomes to immune checkpoint inhibitors in melanoma brain metastases
    Meeting Abstract

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; Zhang, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
    Journal Article

    McKenney, A. S.; Lau, A. N.; Hanasoge Somasundara, A. V.; Spitzer, B.; Intlekofer, A. M.; Ahn, J.; Shank, K.; Rapaport, F. T.; Patel, M. A.; Papalexi, E.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
    Journal Article

    Hobbs, G. S.; Hanasoge Somasundara, A. V.; Kleppe, M.; Litvin, R.; Arcila, M.; Ahn, J.; McKenney, A. S.; Knapp, K.; Ptashkin, R.; Weinstein, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells
    Journal Article

    Kunimoto, H.; McKenney, A. S.; Meydan, C.; Shank, K.; Nazir, A.; Rapaport, F.; Durham, B.; Garrett-Bakelman, F. E.; Pronier, E.; Shih, A. H.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
    Journal Article

    Guryanova, O. A.; Shank, K.; Spitzer, B.; Luciani, L.; Koche, R. P.; Garrett-Bakelman, F. E.; Ganzel, C.; Durham, B. H.; Mohanty, A.; Hoermann, G.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save
  • CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms
    Journal Article

    Meyer, S.; Keller, M.; Chiu, S.; Koppikar, P.; Guryanova, O.; Rapaport, F.; Xu, K.; Manova, K.; Pankov, D.; O'reilly, R.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save